Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 17Observational 3

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Breast Neoplasms 112Neoplasms 73Carcinoma, Non-Small-Cell Lung 36Carcinoma, Renal Cell 35Prostatic Neoplasms 34Colorectal Neoplasms 34Lung Neoplasms 31Melanoma 17Multiple Myeloma 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 11Lymphoma, Follicular 11Colonic Neoplasms 11Stomach Neoplasms 10Lymphoma 10Kidney Neoplasms 10Hematologic Neoplasms 10Rectal Neoplasms 9Arthritis, Rheumatoid 9Recurrence 8Papillomavirus Infections 8Leukemia, Myeloid, Acute 8Carcinoma, Hepatocellular 8Pancreatic Neoplasms 7Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7COVID-19 7Leukemia, Lymphocytic, Chronic, B-Cell 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Has results × Disease Progression × Clear all
NCT02533258 2025-07-16

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Pfizer

Completed
13 enrolled 14 charts
Genitourinary

Carcinoma, Renal Cell, Disease Progression

NCT02392078 2025-04-24

LAANTERN

Monteris Medical

Completed
1,153 enrolled 15 charts
CNS

Brain Neoplasms, Epilepsy, Movement Disorders, Disease Progression

NCT01651078 2024-04-15

LAASR

Monteris Medical

Completed
44 enrolled 8 charts
CNS

Brain Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡